Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
*Correspondence: Frederik Flindt Kreiner, [email protected] This article was submitted to Clinical and Translational Physiology, a section of the journal Frontiers in Physiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Patients with type 2 diabetes face 2-4 times higher cardiovascular disease risk compared to those without diabetes
Kanbay M, Copur S, Siriopol D, Yildiz AB, Gaipov A, van Raalte DH, et al
Researched for insulin sensitivity pathways
Wegovy 2.4 mg weekly for weight management): Demonstrated 15-17% weight loss in STEP trials and significant cardiovascular benefits in SUSTAIN and SELECT trials Liraglutide (Victoza 1.8 mg daily for diabetes
Common side effects were nausea, constipation, diarrhea, fatigue, bloating, abdominal pain, and gastrointestinal problems
